WASHINGTON, D.C. (July 6, 2021)—The Centers for Medicare & Medicaid Service (CMS) has published proposed changes to the Oxygen National Coverage Determination (NCD) based on public comments from last year’s opening of the National Coverage Analysis (NCA) for Home Use of Oxygen Use to Treat Cluster Headaches. Proposed changes include but are not limited to:

LIVINGSTON, Tenn. (June 11, 2021)—Encore Healthcare announced the results from their new oxygen and nebulizer management Nexus TeleRespiratory Care model. Encore used over 20 million data points from chronic respiratory failure patients on home ventilation to build a predictive model that allows home medical equipment (HME) providers to identify when patients need services before they end up in the hospital multiple times.

ARLINGTON, Va. (June 1, 2021)—Home medical equipment (HME) suppliers in rural and other non-bid areas received significant support in the April 2020 Cares Act through measures that extended the 50/50 blended rate for rural suppliers through the COVID-19 public health emergency (PHE), and for the first time provided a 75/25 rate (a blend using 75% current adjusted rates and 25% unadjusted rates) for suppliers in other non-bid areas for the duration of the PHE.

LONDON, U.K. & PLANO, Texas (May 28, 2021)—Belluscura plc, a medical device developer focused on lightweight and portable oxygen enrichment technology, announced that admission to trading on the Alternative Investment Market (AIM) will take place, and dealings will commence at 8:00 a.m. today under the ticker BELL and ISIN GB00BD3B8Z11. AIM is a sub-market of the London Stock Exchange.

WASHINGTON, DC (March 16, 2021)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation's leading home respiratory therapy providers and manufacturing companies—thanked The Centers for Medicare & Medicaid Services (CMS) for the appropriate application of recent legislative action to eliminate the budget neutrality statutory requirement to certain home oxygen equipment and services.

LONDON, U.K. & PLANO, Texas (March 9, 2021)—Belluscura PLC, a medical device developer, has been granted 510(k) clearance and marketing authorization by the U.S. Food and Drug Administration (FDA) for the XPLO2R portable oxygen concentrator (POC). Belluscura developed the X-PLO2R POC with their research partner, Separation Design Group, an award-winning oxygen enrichment research laboratory.

WINTER HAVEN, Fla. (February 23, 2021)—We all know that life has not been the same since the start of the pandemic. 3B Medical wants to make a difference and impact the lives of patients in most need. Starting this month 3B Medical will be sponsoring a contest to give away the newest portable oxygen concentrator on the market, the Aer X. If you know of a deserving patient that is struggling, has a valid oxygen prescription and would be ambulatory if they had a POC, tell us their story.

CINCINNATI, Ohio (February 4, 2021)—Protech Home Medical Corp., a U.S. based provider of home medical equipment, focused on end-to-end respiratory care, announced that it has acquired Mayhugh’s Medical Equipment (MME), a company based in Florida, reporting unaudited trailing 12-month annual revenues of approximately $7 million, adjusted EBITDA (defined below) of $1.2 million, and positive net income.